Equity Overview
Price & Market Data
Price: $0.88
Daily Change: $0.00 / 0.00%
Range: $0.88 - $0.926
Market Cap: $53,658,992
Volume: 79,824
Performance Metrics
1 Week: 1.39%
1 Month: 1.55%
3 Months: -11.99%
6 Months: -7.36%
1 Year: -12.86%
YTD: -7.36%
Company Details
Employees: 10
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States. It is developing KB-9558, a p300 KAT inhibitor development candidate which is in preclinical development for the treatment of multiple myeloma, as well as HPV-driven tumors; and KB-7898, a p300 KAT inhibitor, which is in preclinical development for the treatment of Sjogren's disease. The company was incorporated in 2017 and is headquartered in San Mateo, California.